x

Posted 04 January, 2023

Thorne Healthtech, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:THRN in a 8-K filed on 04 January, 2023.


  In connection with Mr. Conley's resignation, on January 3, 2023, Paul F. Jacobson, the Company's Chief Executive Officer, was appointed to serve as the interim Principal Financial Officer and Principal Accounting Officer of the Company as the Board of Directors undertakes a hiring process for a new CFO.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Thorne Healthtech, Inc.
Health Care/Life Sciences • Pharmaceuticals
Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. It utilizes testing and data to create improved product quality and deliver personalized solutions to consumers, health professionals, and professional sports teams. It also helps pharmaceutical and biotechnology companies repurpose existing drugs and compounds, improve existing medications and develop new products. The company was founded by Paul Jacobson in 2010 and is headquartered in New York, NY.
Market Cap
N/A
View Company Details
Thorne Healthtech, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Arrangements of Certain Officers.

On January 4, 2023, Thorne HealthTech, Inc. (the Company), announced that, on January 1, 2023, Bryan Conley tendered his resignation as the Company's Chief Financial Officer (CFO), effective immediately. In connection with Mr. Conley's resignation, on January 3, 2023, Paul F. Jacobson, the Company's Chief Executive Officer, was appointed to serve as the interim Principal Financial Officer and Principal Accounting Officer of the Company as the Board of Directors undertakes a hiring process for a new CFO.